Oncogenic Impact of TONSL, a Homologous Recombination Repair Protein at the Replication Fork, in Cancer Stem Cells
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24119530 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Hani Lee und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Sookmyung Women's University, Seoul 04310, Republic of Korea. Hauptthemen laut MEDLINE: Neoplasms, Recombinational DNA Repair. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea (NRF) and the Korean government (MSIT).
Abstract (Originalsprache)
We investigated the role of TONSL, a mediator of homologous recombination repair (HRR), in stalled replication fork double-strand breaks (DSBs) in cancer. Publicly available clinical data (tumors from the ovary, breast, stomach and lung) were analyzed through KM Plotter, cBioPortal and Qomics. Cancer stem cell (CSC)-enriched cultures and bulk/general mixed cell cultures (BCCs) with RNAi were employed to determine the effect of TONSL loss in cancer cell lines from the ovary, breast, stomach, lung, colon and brain. Limited dilution assays and ALDH assays were used to quantify the loss of CSCs. Western blotting and cell-based homologous recombination assays were used to identify DNA damage derived from TONSL loss. TONSL was expressed at higher levels in cancer tissues than in normal tissues, and higher expression was an unfavorable prognostic marker for lung, stomach, breast and ovarian cancers. Higher expression of TONSL is partly associated with the coamplification of TONSL and MYC, suggesting its oncogenic role. The suppression of TONSL using RNAi revealed that it is required in the survival of CSCs in cancer cells, while BCCs could frequently survive without TONSL. TONSL dependency occurs through accumulated DNA damage-induced senescence and apoptosis in TONSL-suppressed CSCs. The expression of several other major mediators of HRR was also associated with worse prognosis, whereas the expression of error-prone nonhomologous end joining molecules was associated with better survival in lung adenocarcinoma. Collectively, these results suggest that TONSL-mediated HRR at the replication fork is critical for CSC survival; targeting TONSL may lead to the effective eradication of CSCs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Sookmyung Women's University, Seoul 04310, Republic of Korea.
- Muscle Physiome Research Center, Sookmyung Women's University, Seoul 04310, Republic of Korea.
- Department of Biological Sciences, Sookmyung Women's University, Seoul 04310, Republic of Korea.
- Research Institute of Pharmacal Research, Sookmyung Women's University, Seoul 04310, Republic of Korea.
ORCID-Profile: Yong Kee Kim
Förderung
- National Research Foundation of Korea (NRF) and the Korean government (MSIT)
Zitieren
APA
Lee, H., Ha, S., Choi, S., Do, S., Yoon, S., Kim, Y. K., & Kim, W. Y. (2023). Oncogenic Impact of TONSL, a Homologous Recombination Repair Protein at the Replication Fork, in Cancer Stem Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24119530
Vancouver
Lee H, Ha S, Choi S, Do S, Yoon S, Kim YK, et al. Oncogenic Impact of TONSL, a Homologous Recombination Repair Protein at the Replication Fork, in Cancer Stem Cells. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24119530
BibTeX
@article{Lee2023,
author = {Lee, Hani and Ha, Sojung and Choi, SeokGyeong and Do, Soomin and Yoon, Sukjoon and Kim, Yong Kee and Kim, Woo-Young},
title = {Oncogenic Impact of TONSL, a Homologous Recombination Repair Protein at the Replication Fork, in Cancer Stem Cells},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24119530}
}
EUVIMED